NASDAQ: DERM - Journey Medical Corporation

Rentabilité sur six mois: +3.52%
Rendement en dividendes: 0.00%
Secteur: Healthcare

Calendrier des promotions Journey Medical Corporation

Calendrier avancé Graphique simple
Financial Markets by TradingView

À propos de l'entreprise Journey Medical Corporation

Journey Medical Corporation focuses on the development and commercialization of pharmaceutical products for the treatment of dermatological conditions in the United States.

plus de détails
The company's marketed products include Qbrexza, a medicated cloth towelette for the treatment of primary axillary hyperhidrosis; Accutane, an oral isotretinoin drug to treat severe recalcitrant acne; Targadox, an oral doxycycline drug for adjunctive therapy for severe acne; Zilxi, a topical minocycline treatment for inflammatory lesions; Ximino, an oral minocycline drug for the treatment of moderate to severe acne; and Exelderm cream and solution for topical use. It also sells doxycycline hyclate tablets, minocycline hydrocholoride capsules, and sulconazole nitrate cream and solution. The company was formerly known as Coronado Dermatology, Inc. and changed its name to Journey Medical Corporation. Journey Medical Corporation was incorporated in 2014 and is headquartered in Scottsdale, Arizona. Journey Medical Corporation is a subsidiary of Fortress Biotech, Inc.
Ajouter à la liste de comparaison
Ajouter à la liste de surveillance
Ajouter au portefeuille
Ajouter un avis de prix

IPO date 2021-11-12
ISIN US48115J1097
Industry Biotechnology
Sector Health Care
Валюта usd
Валюта отчета usd
Сайт https://journeymedicalcorp.com
Цена ао 6.14
Changement de prix par jour: -0.4831% (6.21)
Changement de prix par semaine: -5.5% (6.54)
Changement de prix par mois: +16.38% (5.31)
Changement de prix sur 3 mois: +60.94% (3.84)
Changement de prix sur six mois: +3.52% (5.97)
Changement de prix par an: +60.1% (3.86)
Evolution du prix sur 3 ans: +26.38% (4.89)
Evolution des prix depuis le début de l'année: +32.05% (4.68)
Tous les paramètres

Sous-estimation

Nom Signification Grade
P/S 1.6 8
P/BV 6.23 1
P/E 0 0
EV/EBITDA 23.76 5
Total: 3.25

Efficacité

Nom Signification Grade
ROA, % -5.01 0
ROE, % -18.93 0
Total: 0.6667

Dividendes

Nom Signification Grade
Div yield, % 0 0
DSI 0 0
Total: 0.6986

Devoir

Nom Signification Grade
Debt/EBITDA 3.6 3
Total: 7.6

Impulsion de croissance

Nom Signification Grade
Rentabilité Revenue, % 126.88 10
Rentabilité Ebitda, % -70.45 0
Rentabilité EPS, % -195.84 0
Total: 2
Plus de détails

Établissements Volume Partager, %
Renaissance Technologies, LLC 261000 1.87
American Financial Group Inc. 180000 1.29
Vanguard Group Inc 129448 0.93
EAM Investors, LLC 110509 0.79
Neuberger Berman Group, LLC 94479 0.68
Geode Capital Management, LLC 85785 0.62
Millennium Management LLC 75031 0.54
Blackrock Inc. 43892 0.32
NewEdge Advisors, LLC 36592 0.26
Perkins Capital Management, Inc. 32000 0.23



Superviseur Titre d'emploi Paiement Année de naissance
Dr. Lindsay Allan Rosenwald Executive Chairman 50k 1955 (70 années)
Mr. Claude Maraoui Founder, President, CEO & Director 934.45k 1967 (58 années)
Mr. Joseph M. Benesch CFO & Corporate Controller 409.04k 1967 (58 années)
Mr. Andrew J. Zwible Vice President of Operations N/A
Mr. Ramsey Alloush General Counsel & Company Secretary N/A 1986 (39 années)
Mr. Robert Nevin Chief Commercial Officer N/A 1968 (57 années)
Jaclyn Jaffe Senior Director of Corporate Operations N/A

Adresse: United States, Scottsdale. AZ, 9237 East Via de Ventura Boulevard - ouvrir dans Google Maps, ouvrir les cartes Yandex
Site web: https://journeymedicalcorp.com